Literature DB >> 28627823

Hepatitis C: an Overview of Various Laboratory Assays with their Mode of Diagnostic Cooperation.

Mohammad-Ayman A Safi.   

Abstract

BACKGROUND: This review describes in chronological order the different assays for hepatitis C virus (HCV) antibodies, for the core antigen and for the HCV-RNA.
METHODS: By ascending chronological order, the enzyme-linked immunosorbent assay (ELISA), rapid diagnostic tests (RDTs), HCV-Ab IgG avidity index (HCV AI), and Cy3-labeled microarray assay have been described for HCV antibodies in addition to ELISA for the total HCV core antigen (Ag).
RESULTS: The recombinant immunoblot assay (RIBA) is a confirmatory test for HCV-Ab in blood, which is no longer needed due to the use of the sensitive third and fourth generation ELISA in addition to HCV-RNA detection by the Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR). ELISA and RIBA measure current and prior exposure to HCV infection, but cannot discriminate between the two. RT-PCR is performed after ELISA for the diagnosis of HCV infection whether acute, chronic, false positive or false negative ELISA.
CONCLUSIONS: The cooperation between ELISA and RT-PCR in the diagnosis of HCV infection has been tabulated and discussed. HCV genotyping and subtyping testing is essential in pre-treatment evaluation of the patients for setting valuable treatment strategies and in understanding the epidemiology of the virus.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28627823     DOI: 10.7754/Clin.Lab.2016.161113

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  2 in total

1.  Clinical diagnostic performance of light-initiated chemiluminescent assay compared with the Architect chemiluminescence immunoassay for detection of HCV antibody.

Authors:  Shuo Yang; Ruifeng Yang; Siyu Zhang; Di Liu; Jiansuo Zhou; Tiancheng Wang; Liyan Cui
Journal:  J Clin Lab Anal       Date:  2019-05-30       Impact factor: 2.352

2.  The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan.

Authors:  Ying-Chou Huang; Chung-Feng Huang; Shu-Fen Liu; Hung-Yin Liu; Ming-Lun Yeh; Ching-I Huang; Meng-Hsuan Hsieh; Chia-Yen Dai; Shinn-Chern Chen; Ming-Lung Yu; Wan-Long Chuang; Jee-Fu Huang
Journal:  PLoS One       Date:  2021-01-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.